2 not yet recruiting, 2 recruiting. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Not yet recruiting 2, Recruiting 2 |
Follow GLP - 1: new trials by email Literature Review of GLP - 1 trials Research Report on GLP - 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GLP-1s in Hip and Knee Arthroplasty GLP-1 Receptor Agonists + Behavioral modification, Behavioral + placebo - Arthritis, Obesity & Overweight | Phase 4 | Not yet recruiting | Nova Scotia Health Authority | 100 | 2026-10-01 | 2026-08-10 |
| Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1 Semaglutide, Dietary Counseling, Exercise - GLP - 1, Obesity & Overweight | Phase 4 | Not yet recruiting | William Marsh Rice University | 20 | 2026-04-06 | 2026-04-28 |
| Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder Group Therapy Program, semaglutide, Phentermine-Topiramate - Bipolar I Disorder, Bipolar II Disorder | Phase 4 | Recruiting | Mayo Clinic | 100 | 2026-01-19 | 2026-03-11 |
| The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality Continue GLP/GIP - GLP - 1, Bowel Preparation for Colonoscopy | Phase 4 | Recruiting | The Cleveland Clinic | 132 | 2025-08-01 | 2025-12-04 |
Obesity (3) · Overweight (2) · Arthritis (1) · Bipolar Disorder (1) · Muscular Atrophy (1) · Psychotic Disorders (1) · Weight Loss (1)
Body Weight (3) · Nutrition Disorders (3) · Nutritional and Metabolic Diseases (3) · Overnutrition (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Atrophy (1) · Bipolar and Related Disorders (1) · Body Weight Changes (1) · Joint Diseases (1) · Mental Disorders (1) · Mood Disorders (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1)
semaglutide (2) · Behavior Therapy (1) · Exercise (1) · Glucagon-Like Peptide-1 Receptor Agonists (1) · Naltrexone-Bupropion combination (1) · Nutrition Assessment (1) · Qsymia (1)
Mayo Clinic (1) · Nova Scotia Health Authority (1) · The Cleveland Clinic (1) · William Marsh Rice University (1)
United States (3) · Canada (1)